Peripheral lung tumours occasionally arise in association with focal, but more usually diffuse scarring. A causal relation was suggested by the finding during routine necropsies of unsuspected early malignancy adjacent to scars.' Although the pathogenesis is unclear, possible mechanisms include uncontrolled epithelial hyperplasia in relation to bland fibrosis or the concentration of carcinogens by scars.2 Carcinogenic properties of some fibrogenic agents such as asbestos or of scar components, namely elastic3 and cholesterol4 are also incriminated. Scarring is seen in up to 40 % of surgical resections and 10% of necropsies.5 Forty-five per cent of adenocarcinomas in men6 and 25% of all lung tumours7 are scar-related. Significantly scar cancers are becoming more common in America8 while smoking-induced tumours there are expected to decline.9
This paper records the frequency of scar cancer in a population generally free of fibrogenic hazards though prone to one form of lung scarring, tuberculosis.
Material and methods
One hundred consecutive necropsies involving primary lung carcinoma were reviewed. The patients' hospital records, necropsy protocols and all of the tissue sections were studied. Clinical data, particularly residence, occupation, smoking habit and previous respiratory illness was noted (Fig. 2) . Each showed elastosis in blood vessels and alveoli within and adjacent to tumour. Where these structures were being enveloped and distorted by tumour the impression of stromal elastosis was enhanced (Fig. 3) . Anthracotic pigment was usually perivascular but after tissue distortion appeared to lie in tumour stroma closely applied to elastosis and fibrosis (Fig.  4) . These areas were frequently so compact that it was only after careful study of sections stained for elastic that the components of the scar could be identified (Fig. 5) . We also frequently observed small areas of interstitial lung fibrosis immediately adjacent to tumour. After compression and collapse this resembled "bronchiolisation" and "adenomatosis." Seven patients in this group were smokers. Ten were judged clinically or pathologically (or by both) to have chronic airways disease. Six tumours were squamous carcinomas, three were oat cell carcinomas and two were adenocarcinomas.
Discussion
The higher incidence of lung scar cancer reported by others3 5- that any tumour but especially adenocarcinomas cause scarring in a non-specific way.
We believe most of the tumours we studied were caused by agents other than scars. Eighty-seven per cent of our patients had chronic obstructive airways disease, and 620% smoked cigarettes until their deaths. Air pollution in Dublin is similar to that of industrialised England.'2 Moreover, the view that malignancy occurs in pre-existing lung scars irrespective of smoking habit'3 is unacceptable.
Lung scar cancer cannot be diagnosed merely Lung scar cancer-a reappraisal because microscopic scarring is seen within a tumour. Carcinoma originating at the edge of a scar, especially one large enough to be seen naked eye, is likely to represent this entity. As more patients survive serious chest diseases, notably infections, it is probable that pulmonary scarring and subsequent malignancy will increase. Our figure of 3 % represents a more accurate assessment of the incidence now, if criteria are critically applied.
